How Does HDR Brachytherapy Work?
HDR brachytherapy uses a highly radioactive source, often
iridium-192 or
cesium-137, which is temporarily placed within a special applicator that has been positioned in the treatment area. The procedure is usually performed in an outpatient setting. The radioactive source is controlled by a computer and is precisely placed to maximize the dose to the cancer cells while protecting normal tissues.
Precision: The ability to deliver a high dose of radiation directly to the tumor with minimal impact on surrounding healthy tissues.
Shorter Treatment Times: HDR brachytherapy typically involves shorter treatment sessions compared to external beam radiation therapy.
Outpatient Procedure: Most HDR brachytherapy treatments can be performed on an outpatient basis, reducing hospital stays and recovery times.
Effective for Recurrent Cancers: HDR brachytherapy can be an effective option for treating recurrent cancers that have previously been treated with radiation.
Planning: Imaging studies such as
CT scans or
MRI are used to create a detailed map of the tumor and surrounding structures.
Applicator Placement: A specialized applicator is placed into the treatment area under anesthesia or sedation. This applicator holds the radioactive source.
Treatment Delivery: The radioactive source is inserted into the applicator using a computer-controlled device. The source remains in place for a specific duration, typically a few minutes, to deliver the prescribed dose of radiation.
Removal: The applicator and radioactive source are removed after the treatment session is complete.
Who is a Candidate for HDR Brachytherapy?
Candidates for HDR brachytherapy are typically patients with localized gynecological cancers who have not responded to other treatments or who are seeking an alternative to surgery. The suitability of HDR brachytherapy depends on factors such as the size and location of the tumor, the patient's overall health, and previous treatments received.
What Should Patients Expect During Recovery?
Recovery from HDR brachytherapy is usually quick, with most patients resuming normal activities within a few days. Patients may experience mild discomfort or spotting, but these symptoms typically resolve within a short period. Follow-up appointments are essential to monitor for any potential side effects and to assess the effectiveness of the treatment.
Conclusion
HDR brachytherapy is a valuable treatment option for certain gynecological cancers, offering precision and effectiveness with a relatively quick recovery time. Consulting with a
gynecologic oncologist can help determine if HDR brachytherapy is the right choice based on individual circumstances and treatment goals.